T1	Participants 74 120	in patients with amyotrophic lateral sclerosis
T2	Participants 183 244	Fifty-seven patients with amyotrophic lateral sclerosis (ALS)
T3	Participants 485 498	some patients
T4	Participants 900 989	most patients tested after 2 weeks of continuous treatment and 4 weeks' withdrawal period
T5	Participants 1067 1084	patients with ALS
T6	Participants 1232 1259	human motor neuron diseases
